Support Line: 0800 002 9002
General Enquiries: 01223 870008


News Archive

MHRA

MHRA authorises cancer treatment variation with an administration time of 3–5 minutes

MHRA authorises cancer treatment variation with an administration time of 3–5 minutes

On 30 April 2025, the Medicines and Healthcare Products Regulatory Agency (MHRA) approved a new under-the-skin ...
No results found.